Trial Site Detail

 

Drug:
Regorafenib (SDH)
Trial:
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (REGISTRI)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Istituto Nazionale Dei Tumori

via Giacomo     
Milan , 20133
Italy

 

Principal Investigator:
Paolo Casali MD
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Istituto Nazionale Dei Tumori Website:
http://www.istitutotumori.mi.it/INT/default.asp

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.